Science Explorer Interactive view Map

Madrigal Pharmaceuticals (United States)

Research works
51
▲ 449% vs 2013–17
Citations
447
8.8 per fractional work
Top-10% rate
11.0%
record average 16.5%
Open access
55%
world 28%

Not ranked overall: Madrigal Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

What does Madrigal Pharmaceuticals (United States) specialise in?

Where its research is concentrated relative to its size: Medicine takes 4.5× the share of its output that it takes of world research.

  1. MedicineField · 32.3 works4.5×
  2. Health SciencesDomain · 32.7 works3.8×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.85× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 0.22× its world share, 0 worksImmunology and Micro…Neuroscience: 0.07× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 5.62× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.19× its world share, 1 worksChemistryComputer Science: 0.08× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringHealth Professions: 0.11× its world share, 0 worksHealth ProfessionsMedicine: 4.46× its world share, 32 worksMedicineNursing: 1.81× its world share, 0 worksNursingBusiness, Management and Accounting: 0.27× its world share, 0 worksBusiness, Management…Decision Sciences: 0.05× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.76× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.07× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.6×. Every wedge is a field page.

Which keywords describe research at Madrigal Pharmaceuticals (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Metabolic Syndrome, Insulin Resistance, Hepatic Steatosis, Hepatocellular Carcinoma, NAFLD, NASH, Inflammation and Cardiovascular Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Metabolic Syndrome18▲ 59×5 topics
  2. Insulin Resistance15▲ 89×5 topics
  3. Hepatic Steatosis14▲ 242×2 topics
  4. Hepatocellular Carcinoma12▲ 156×2 topics
  5. NAFLD12▲ 271×1 topic
  6. NASH12▲ 271×1 topic
  7. Inflammation7▲ 9.1×13 topics
  8. Cardiovascular Disease6▲ 13×6 topics
  9. Obesity5▲ 17×5 topics
  10. Weight Loss3▲ 54×2 topics
  11. Glucose Metabolism3▲ 83×2 topics
  12. Oxidative Stress3▲ 4.8×5 topics
  13. Diabetes2▲ 13×3 topics
  14. Epidemiology2▲ 1.54×10 topics
  15. Ketogenic Diet2▲ 64×1 topic
  16. Low-Carbohydrate Diet2▲ 71×1 topic
  17. Lifestyle Intervention2▲ 69×2 topics
  18. Atherosclerosis2▲ 19×2 topics
  19. Diagnosis2▲ 5.5×6 topics
  20. Fructose2▲ 142×1 topic
  21. Hypertension2▲ 17×1 topic
  22. Hepatic Encephalopathy2▲ 84×1 topic
  23. Liver Cirrhosis2▲ 84×1 topic
  24. Type 2 Diabetes2▲ 21×2 topics
  25. Treatment2▲ 3.4×5 topics
  26. Hepatic Stellate Cells2▲ 242×1 topic
  27. Liver Regeneration2▲ 242×1 topic
  28. Management1▲ 4.8×5 topics
  29. Liver Transplantation1▲ 28×2 topics
  30. Cholesterol1▲ 23×1 topic
  31. Global Prevalence1▲ 36×1 topic
  32. Heart Failure1▲ 7.4×2 topics
  33. Pathogenesis1▲ 6.0×4 topics
  34. Cardiovascular Risk1▲ 9.4×2 topics
  35. Cognitive Impairment1▲ 12×2 topics
  36. Genetic Polymorphisms1▲ 54×2 topics
  37. Bariatric Surgery1▲ 81×1 topic
  38. Folate1▲ 97×1 topic
  39. Homocysteine1▲ 97×1 topic
  40. Metabolic Surgery1▲ 81×1 topic

Which research topics does Madrigal Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Liver Disease Diagnosis and Treatment, Diet and metabolism studies, Diet, Metabolism, and Disease and Liver Disease and Transplantation.

  1. 1 Liver Disease Diagnosis and Treatment Epidemiology 12 works
  2. 2 Diet and metabolism studies Physiology 2 works
  3. 3 Diet, Metabolism, and Disease Endocrinology, Diabetes and Metabolism 2 works
  4. 4 Liver Disease and Transplantation Hepatology 2 works
  5. 5 Liver physiology and pathology Hepatology 2 works
  6. 6 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
  7. 7 Bariatric Surgery and Outcomes Surgery 1 works
  8. 8 Folate and B Vitamins Research Rheumatology 1 works
  9. 9 Cardiovascular Disease and Adiposity Cardiology and Cardiovascular Medicine 1 works
  10. 10 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available55.3%not open44.7%

World: 28% of research is openly available.

with international co-authors23.2%domestic only76.8%

World: 19% is written across borders.

How has Madrigal Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 449% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in West Conshohocken

All research institutions in West Conshohocken

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.